IRIC discoveries have spurred major advances in understanding the development of cancer and opened the way to the creation of new, more targeted therapeutic solutions. Its publications are a reflection of these accomplishments. They also demonstrate the Institute’s drive and productivity.
Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance.Immunol. Rev. 2017-11-01;280(1):165-174.
WD40 repeat domain proteins: a novel target class?Nat Rev Drug Discov 2017-10-13.
Ang-(1-7) is an endogenous β-arrestin-biased agonist of the AT1 receptor with protective action in cardiac hypertrophy.Sci Rep 2017-09-19;7(1):11903.
Single Electron Transistor with Single Aromatic Ring Molecule Covalently Connected to Graphene Nanogaps.Nano Lett. 2017-09-13;17(9):5335-5341.
Identification of novel biomarkers for MLL translocated acute myeloid leukemia.Exp. Hematol. 2017-09-11.
Functional New World monkey oxytocin forms elicit an altered signaling profile and promotes parental care in rats.Proc. Natl. Acad. Sci. U.S.A. 2017-08-22;114(34):9044-9049.
Exploiting non-canonical translation to identify new targets for T cell-based cancer immunotherapy.Cell. Mol. Life Sci. 2017-08-19.